StonvexLoading…
StonvexStonvexStonvexCore line items from AMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.12B | $2.95B | $3.46B | $4.09B |
Operating Income | $-61.37M | $227.85M | $863.09M | $1.58B |
Net Income | $-61.69M | $187.58M | $721.96M | $1.45B |
EPS (Diluted) | $-4.75 | $14.28 | $49.30 | $79.49 |
Total Assets | $2.28B | $2.44B | $2.41B | $2.31B |
Total Liabilities | $735.13M | $789.21M | $832.13M | $882.72M |
Cash & Equivalents | $365.97M | $481.58M | $268.21M | $301.91M |
Free Cash Flow OCF − CapEx | $17.77M | $381.07M | $605.79M | $1.32B |
Shares Outstanding | 12.81M | 13.02M | 12.94M | 15.55M |